A method to predict breast cancer stage using Medicare claims
Tóm tắt
In epidemiologic studies, cancer stage is an important predictor of outcomes. However, cancer stage is typically unavailable in medical insurance claims datasets, thus limiting the usefulness of such data for epidemiologic studies. Therefore, we sought to develop an algorithm to predict cancer stage based on covariates available from claims-based data. We identified a cohort of 77,306 women age ≥ 66 years with stage I-IV breast cancer, using the Surveillence Epidemiology and End Results (SEER)-Medicare database. We formulated an algorithm to predict cancer stage using covariates (demographic, tumor, and treatment characteristics) obtained from claims. Logistic regression models derived prediction equations in a training set, and equations' test characteristics (sensitivity, specificity, positive predictive value (PPV), and negative predictive value [NPV]) were calculated in a validation set. Of the entire sample of women diagnosed with invasive breast cancer, 51% had stage I; 26% stage II; 11% stage III; and 4% stage IV disease. The equation predicting stage IV disease achieved sensitivity of 81%, specificity 89%, positive predictive value (PPV) 24%, and negative predictive value (NPV) 99%, while the equation distinguishing stage I/II from stage III disease achieved sensitivity 83%, specificity 78%, PPV 98%, and NPV 31%. Combined, the equations most accurately identified early stage disease and ascertained a sample in which 98% of patients were stage I or II. A claims-based algorithm was utilized to predict breast cancer stage, and was particularly successful when used to identify early stage disease. These prediction equations may be applied in future studies of breast cancer patients, substantially improving the utility of claims-based studies in this group. This method may similarly be employed to develop algorithms permitting claims-based epidemiologic studies of patients with other cancers.
Tài liệu tham khảo
Goff DC Jr, Pandey DK, Chan FA, Ortiz C, Nichaman MZ: Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project. Arch Intern Med 2000, 160:197–202.
Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH: Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 2004, 148:99–104.
Leibson CL, Needleman J, Buerhaus P, Heit JA, Melton LJ, Naessens JM, Bailey KR, Petterson TM, Ransom JE, Harris MR: Identifying in-hospital venous thromboembolism (VTE): a comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort. Med Care 2008, 46:127–132.
Noyes K, Liu H, Holloway R, Dick AW: Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey. Mov Disord 2007, 22:509–514.
Winkelmayer WC, Schneeweiss S, Mogun H, Patrick AR, Avorn J, Solomon DH: Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis 2005, 46:225–232.
Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL: Use of SEER-Medicare data for measuring cancer surgery. Med Care 2002, 40:43–48.
Cooper GS, Yuan Z, Stange KC, Dennis LK, Amini SB, Rimm AA: Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment. Med Care 2000, 38:411–421.
Du X, Freeman JL, Goodwin JS: Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results. J Clin Epidemiol 1999, 52:463–470.
Du X, Goodwin JS: Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. J Clin Oncol 2001, 19:1455–1461.
Du XL, Chan W, Giordano S, Geraci JM, Delclos GL, Burau K, Fang S: Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity. Cancer 2005, 104:913–924.
Nattinger AB, Laud PW, Bajorunaite R, Sparapani RA, Freeman JL: An algorithm for the use of Medicare claims data to identify women with incident breast cancer. Health Serv Res 2004, 39:1733–1749.
Virnig BA, Warren JL, Cooper GS, Klabunde CN, Schussler N, Freeman J: Studying radiation therapy using SEER-Medicare-linked data. Med Care 2002, 40:49–54.
Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB: Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 2002, 40:55–61.
Ko CY, Parikh J, Zingmond D: Secondary analyses of large population-based data sets: issues of quality, standards, and understanding. Ann Surg Oncol 2008, 15:395–396.
Nathan H, Pawlik TM: Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol 2008, 15:415–423.
Woodward WA, Strom EA, Tucker SL, McNeese MD, Perkins GH, Schechter NR, Singletary SE, Theriault RL, Hortobagyi GN, Hunt KK, Buchholz TA: Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol 2003, 21:3244–3248.
Cooper GS, Yuan Z, Stange KC, Amini SB, Dennis LK, Rimm AA: The utility of Medicare claims data for measuring cancer stage. Med Care 1999, 37:706–711.
Gozalo PL, Miller SC: Hospice enrollment and evaluation of its causal effect on hospitalization of dying nursing home patients. Health Serv Res 2007, 42:587–610.
Case C, Johantgen M, Steiner C: Outpatient mastectomy: clinical, payer, and geographic influences. Health Serv Res 2001, 36:869–884.
Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG: Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 2006, 98:681–690.
US Department of Health and Human Services Cancer Statistics Branch. SEER Manuals Extent of Disease--1998 Codes and Coding Instructions [National Cancer Institute Surveillance Epidemiology and End Results web site] [http://www.seer.cancer.gov/manuals/EOD10Dig.3rd.pdf] 1998.
Greene FL, Page DL, Fleming ID: AJCC Cancer Staging Manual. 6th edition. New York: Springer Science & Business Media; 2003.
Smith BD, Haffty BG, Buchholz TA, Smith GL, Galusha DH, Bekelman JE, Gross CP: Effectiveness of radiation therapy in older women with ductal carcinoma in situ. J Natl Cancer Inst 2006, 98:1302–1310.
Smith BD, Haffty BG, Smith GL, Hurria A, Buchholz TA, Gross CP: Use of postmastectomy radiotherapy in older women. Int J Radiat Oncol Biol Phys 2008, 71:98–106.
Smith BD, Smith GL, Buchholz TA: Controversies over the role of radiation therapy for ductal carcinoma in situ. Expert Rev Anticancer Ther 2008, 8:433–441.
Smith BD, Smith GL, Haffty BG: Postmastectomy radiation and mortality in women with T1–2 node-positive breast cancer. J Clin Oncol 2005, 23:1409–1419.
Smith GL, Smith BD, Giordano SH, Shih YC, Woodward WA, Strom EA, Perkins GH, Tereffe W, Yu TK, Buchholz TA: Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer 2008, 112:1371–1379.
Klabunde CN, Potosky AL, Legler JM, Warren JL: Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000, 53:1258–1267.
Research Data Assistance Center: Medicare data available [http://www.resdac.umn.edu/Medicare/data_available.asp]
Nattinger AB, Laud PW, Bajorunaite R, Sparapani RA, Freeman JL: An algorithm for the use of Medicare claims data to identify women with incident breast cancer. Health Serv Res 2004, 39:1733–49.
National Cancer Data Base (NCDB) [http://cromwell.facs.org/BMarks/BMPub/Ver10/DxRx/BMPub_DxRx.cfm]